Johan Quensel is a senior project manager with over 20 years’ experience of pharmaceutical development and design of clinical development programs and clinical trials, from early phase to market.

      • Over the years management of several clinical trials and development teams with focus on delivering high quality results enabling sound decision making.
      • Expertise in outsourcing clinical studies and programs, including identifying vendors and preparing work orders.
      • A broad work experience from working with CROs, smaller biotech, and larger pharmaceutical companies brings a good insight in a variety of organisations.
      • Therapeutic knowledge in dermatology; psoriasis, atopic dermatitis, seborrheic dermatitis and itch as well as immunology; tuberculosis and children vaccines.
Current position: CEO, Consultant, Q Clinical Research Consulting, Sweden 2015 –
Previous positions: International Clinical Project Manager, LEO Pharma, Denmark 2009   – 2014
Clinical Development Manager, Astion Pharma, Denmark 2006   – 2009
Senior Medical Adviser, Statens Serum Institut, Denmark 1999   – 2005
Clinical Trial Manager, Perstorp Pharma, Sweden 1997   – 1998
Clinical Trial Manager, Hylae Clinical Research AB, Sweden 1992   – 1996
Education Licentiate of Science, Biochemistry, Lund University 1991
M. Sci. Chemistry, Lund University 1987
Q CRC Johan Quensel

Johan Quensel
Fil.Lic
Chief Executive Officer

The office is situated at
Lärarvägen 12
SE-247 45 Torna Hällestad
Sweden

Mobile: +46 (0)760 46 67 44
jq@qcrc.se

Photo; Peter Frodin